AstraZeneca PLC

{ "date": [ "202612", "202712", "202812" ], "revenue_estimate": [ 64620.57, 68745.66, 72823.8 ], "ebit_estimate": [ 20447.26, 22761.84, 24648.29 ], "ebitda_estimate": [ 23450.46, 25887.69, 28017.56 ], "net_income_estimate": [ 16000.35, 18099.77, 20250.79 ], "per_share_eps_estimate": [ 8.44, 9.79, 10.86 ], "eps_nri_estimate": [ 10.46, 11.79, 12.93 ], "dividend_estimate": [ 3.43, 3.61, 3.75 ], "book_value_per_share_estimate": [ 35.69, 41.05, 47.83 ], "pretax_income_estimate": [ 19066.03, 21626.15, 24954.73 ], "operating_cash_flow_per_share_estimate": [ 11.2, 10.95, 13.66 ], "roa_estimate": [ 11.85, 12.7, 13.23 ], "roe_estimate": [ 28.24, 28.06, 25.27 ], "gross_margin_estimate": [ 82.97, 83.43, 83.81 ], "operating_cash_flow_estimate": [ 17511.51, 17117.82, 21345.62 ], "pettm_estimate": [ 24.03, 20.71, 18.68 ], "long_term_growth_rate_mean": 24.72, "long_term_revenue_growth_rate_mean": "6.85", "future_per_share_eps_estimate_growth": 17.64, "future_eps_nri_estimate_growth": 24.72, "future_revenue_estimate_growth": 6.85, "future_ebit_estimate_growth": 19.2, "future_ebitda_estimate_growth": 12.08, "future_dividend_estimate_growth": 5.61, "future_net_income_estimate_growth": 23.72, "future_pretax_income_estimate_growth": 24.35, "future_book_value_per_share_estimate_growth": 14.57, "future_roa_estimate_growth": 12.59, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": 0.75, "future_operating_cash_flow_per_share_estimate_growth": 11.35 }

{ "date": [ "202603", "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 15191.4, 15719.65, 16448.04, 17270.26, 15991.62, 16612.61, 17587.7, 17921.29 ], "ebit_estimate": [ 5199.03, 5149.83, 5487.48, 5477.36, null, null, null, null ], "ebitda_estimate": [ 7675.92, 7479.96, 7948.08, 7754.69, null, null, null, null ], "net_income_estimate": [ 4001.2, 3935.64, 4208.72, 3757.69, 4542.93, 4279.14, 4728.72, 4196 ], "per_share_eps_estimate": [ 2.04, 2.03, 2.19, 2.19, null, null, null, null ], "eps_nri_estimate": [ 2.6, 2.55, 2.73, 2.52, 3.07, 2.85, 3.15, 2.68 ], "dividend_estimate": [ 0.87, 0.87, 0.87, 0.87, 0.92, 0.92, 0.92, 0.92 ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ 4959.62, 4947.34, 5230.29, 5231.87, null, null, null, null ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null, null ], "gross_margin_estimate": [ 82.95, 82.78, 82.35, 81.33, 84.5, 83.2, 82.6, 80.8 ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null, null ], "pettm_estimate": [ 23.99, null, null, null, null, null, null, null ], "long_term_growth_rate_mean": 24.72, "long_term_revenue_growth_rate_mean": "6.85", "future_per_share_eps_estimate_growth": 17.64, "future_eps_nri_estimate_growth": 24.72, "future_revenue_estimate_growth": 6.85, "future_ebit_estimate_growth": 19.2, "future_ebitda_estimate_growth": 12.08, "future_dividend_estimate_growth": 5.61, "future_net_income_estimate_growth": 23.72, "future_pretax_income_estimate_growth": 24.35, "future_book_value_per_share_estimate_growth": 14.57, "future_roa_estimate_growth": 12.59, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": 0.75, "future_operating_cash_flow_per_share_estimate_growth": 11.35 }